The company was founded in 1901 by Hungarian pharmacist Gedeon Richter. Today Gedeon Richter Richter has grown to become a multinational pharmaceutical company, headquartered in Budapest. The company's products are distributed in more than 100 countries and it employs around 11,000 people worldwide. Innovation and the research of original drug molecules have always been key elements in the Company's strategy. With 1000 employees in the field of research and development, Gedeon Richter's main areas of focus are the treatment of benign gynaecological conditions and diseases of the central nervous system. The Women's Health Division of Richter is dedicated to the development and commercialisation of innovative drugs for women's reproductive medicine. The company is one of very few in the world to offer a comprehensive portfolio of products for gynaecological conditions. R&D activities within Women's Health focus on developing non-invasive medical treatments for common gynaecological conditions which are currently under-treated. Many of these conditions can have a severe impact on the patient's quality of life. The company has a pipeline of innovative compounds which includes several first in class molecules with development stages spanning from pre-clinical to newly licensed.